BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1395816)

  • 1. Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis.
    Ohar JA; Jackson F; Dettenmeier PA; Bedrossian CW; Tricomi SM; Evans RG
    Chest; 1992 Oct; 102(4):999-1004. PubMed ID: 1395816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature.
    Coudert B; Bailly F; Lombard JN; Andre F; Camus P
    Chest; 1992 Oct; 102(4):1005-12. PubMed ID: 1395734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients.
    Akoun GM; Cadranel JL; Blanchette G; Milleron BJ; Mayaud CM
    Chest; 1991 May; 99(5):1177-82. PubMed ID: 1673380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis.
    Xaubet A; Roca J; Rodriguez-Roisin R; Herranz J; Marin A; Lomeña F; Montserrat JM; Agustí-Vidal A
    Respiration; 1987; 52(4):272-80. PubMed ID: 3438590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone-induced pulmonary toxicity. Immunoallergologic tests and bronchoalveolar lavage phospholipid content.
    Nicolet-Chatelain G; Prevost MC; Escamilla R; Migueres J
    Chest; 1991 Feb; 99(2):363-9. PubMed ID: 1989796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
    Jolly E; Belloti MS; Lowenstein J; Luna C; Avagnina A; Elsner B; Mazzei JA
    Medicina (B Aires); 1991; 51(1):19-25. PubMed ID: 1921687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic values of BAL and TBLB in patients with interstitial lung diseases].
    Matsuda K; Satoh M; Kawanami O
    Nihon Ika Daigaku Zasshi; 1992 Apr; 59(2):155-65. PubMed ID: 1577918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary toxicity of amiodarone].
    Sevillano Martín C; Callol Sánchez L; Calderón Alvarez J; Moreno Muro M; Gómez de Terreros FJ
    Rev Clin Esp; 1989 Nov; 185(7):362-5. PubMed ID: 2623252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis.
    Laviolette M; La Forge J; Tennina S; Boulet LP
    Chest; 1991 Aug; 100(2):380-4. PubMed ID: 1864110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis.
    Winterbauer RH; Lammert J; Selland M; Wu R; Corley D; Springmeyer SC
    Chest; 1993 Aug; 104(2):352-61. PubMed ID: 8339618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multinuclear giant cells in bronchoalveolar lavage in interstitial lung diseases.
    Agustí C; Xaubet A; Arriols R; Marín A; Montserrat JM; Agustí-Vidal A
    Respiration; 1987; 51(4):307-11. PubMed ID: 3659580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of bronchoalveolar lavage in interstitial lung diseases.
    Potdar PV; Jain K; Prabhakaran L; Kamat SR
    J Assoc Physicians India; 1989 Jul; 37(7):444-7. PubMed ID: 2693446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumonitis induced by amiodarone].
    Terra Filho M; Vargas FS; Cukier A; Teixeira LR; Pinto RM; Pileggi F
    Arq Bras Cardiol; 1989 Oct; 53(4):201-5. PubMed ID: 2483501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.
    Kang IS; Kim KJ; Kim Y; Park SH
    Korean J Intern Med; 2014 Nov; 29(6):746-53. PubMed ID: 25378973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoalveolar lavage in interstitial lung disease: effect of volume of fluid infused.
    Helmers RA; Dayton CS; Floerchinger C; Hunninghake GW
    J Appl Physiol (1985); 1989 Oct; 67(4):1443-6. PubMed ID: 2793747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchoalveolar lavage in interstitial lung diseases: does the recovery rate affect the results?
    Schildge J; Nagel C; Grun C
    Respiration; 2007; 74(5):553-7. PubMed ID: 17496412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry.
    Bedrossian CW; Warren CJ; Ohar J; Bhan R
    Ann Diagn Pathol; 1997 Oct; 1(1):47-56. PubMed ID: 9869825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis.
    Emad A; Rezaian GR
    Chest; 1999 May; 115(5):1346-51. PubMed ID: 10334151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.